A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.
Nijstad AL, de Vos-Kerkhof E, Enters-Weijnen CF, van de Wetering MD, Tissing WJE, Hanff LM, Lange R, Tibben MM, Rosing H, Lalmohamed A, Zwaan CM, Huitema ADR.
Nijstad AL, et al. Among authors: rosing h.
J Oncol Pharm Pract. 2023 Jun;29(4):899-904. doi: 10.1177/10781552221089243. Epub 2022 Apr 4.
J Oncol Pharm Pract. 2023.
PMID: 35377726